Salvage radiotherapy for biochemical recurrence after radical prostatectomy

BJU International

Volumn 96, Issue 7, 2005, Pages 1009-1013

  Terai, Akito ^a   Matsui, Yoshiyuki ^a   Yoshimura, Koji ^a   Arai, Yoichi ^a   Dodo, Yoshihiro ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Biochemical failure; Prostate cancer; PSA; Radical prostatectomy; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ADENOCARCINOMA; AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 27444446115     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05746.x     Document Type: Article

References (26)

1. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-7
2. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169: 517-23
3. Scattoni V, Montorsi F, Picchio M et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004; 93: 680-8
4. Garg MK, Tekyi-Mensah S, Bolton S et al. Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. Urology 1998; 51: 998-1002
5. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 1998; 159: 173-8
6. Nudell DM, Grossfeld GD, Weinberg VK, Roach M 3rd, Carroll PR. Radiotherapy after radical prostatectomy. treatment outcomes and failure patterns. Urology 1999; 54: 1049-57
7. Pisansky TM, Kozelsky TF, Myers RP et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 2000; 163: 845-50
8. Anscher MS, Clough R, Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Phys 2000; 48: 369-75
9. Vanuytsel L, Janssens G, Van Poppel H, Rijnders A, Baert L. Radiotherapy for PSA recurrence after radical prostatectomy. Eur Urol 2001; 39: 425-9
10. Catton C, Gospodarowicz M, Warde P et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 2001; 59: 51-60
11. Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2001; 19: 1030-9
12. Song DY, Thompson TL, Ramakrishnan V et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002; 60: 281-7
13. Choo R, Hruby G, Hong J et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2002; 53: 269-76
14. Chawla AK, Thakral HK, Zietman AL, Shipley WU. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma. analysis of efficacy and prognostic factors. Urology 2002; 59: 726-31
15. MacDonald OK, Schild SE, Vora SA et al. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol 2003; 170: 1833-7
16. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003; 21: 483-9
17. Liauw SL, Webster WS, Pistenmaa DA, Roehrborn CG. Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience. Urology 2003; 61: 1204-10
18. Matsui Y, Ichioka K, Terada N et al. Impact of volume weighted mean nuclear volume on outcomes following salvage radiation therapy after radical prostatectomy. J Urol 2004; 171: 687-91
19. Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 1325-32
20. Sobin LH, Wittekind CH eds, TNM Classification of Malignant Tumours, 6th edn. New York: Wiley 2002
21. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate specific antigen levels after radical prostatectomy. J Clin Oncol 1999; 17: 1155-63
22. Arai Y, Okubo K, Aoki Y, Maekawa S, Okada T, Maeda H. Ultrasensitive assay of prostate-specific antigen for early detection of residual cancer after radical prostatectomy. Int J Urol 1998; 5: 550-5
23. Vassilikos EJ, Yu H, Trachtenberg J et al. Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up. Clin Biochem 2000; 33: 115-23
24. Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Urology 2003; 61: 365-9
25. Anscher MS. Salvage radiotherapy for recurrent prostate cancer: the earlier the better. JAMA 2004; 291: 1380-2
26. Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Int J Radiat Oncol Biol Phys 2005; 61: 714-24